Home
Conditions
Substance-Related Disorders

Clinical trial condition

Substance-Related Disorders

Explore clinical trials studying Substance-Related Disorders. Study availability and eligibility vary by location and protocol.

4,198 public trials 568 recruiting studies

Refine in advanced search Browse all conditions

Substance-Related Disorders trial results

Completed

Baclofen Effects in Cigarette Smokers

NCT01821560

Conditions: Chemically-Induced Disorders, Mental Disorders, Nicotine Dependence, +2 more
Locations: University of Pennsylvania Center for Studies of Addiction Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Acamprosate vs. Placebo in Bipolar Alcoholics

NCT00466661

Conditions: Alcohol Dependence, Alcohol-Related Disorders, Alcoholism, +15 more
Locations: Institute of Psychiatry, Medical University of South Carolina Charleston, South Carolina, United States

View Trial Details

Completed

Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal

NCT03489161

Conditions: Chemically-Induced Disorders, Drug Misuse, Drug Overdose, +7 more
Locations: Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)

NCT02942199

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: Cambridge Health Alliance Cambridge, Massachusetts, United States

View Trial Details

Completed

Electronic Decision Support Systems for Smokers With Severe Mental Illness

NCT01412866

Conditions: Behavior, Chemically-Induced Disorders, Mental Disorders, +7 more
Locations: Thresholds Psychiatric Rehabilitation Center Chicago, Illinois, United States

View Trial Details

Completed

ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals

NCT00834080

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: Alkermes Clinical Study Site Colton, California, United States

Alkermes Clinical Study Site Oceanside, California, United States

Alkermes Clinical Study Site Lauderhill, Florida, United States

Alkermes Clinical Study Site Hoffman Estates, Illinois, United States

View Trial Details

Completed

Impact of Varenicline on Blood-Oxygen-Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Activation on Smokers

NCT00934024

Conditions: Behavior, Chemically-Induced Disorders, Mental Disorders, +4 more
Locations: Medical University of South Carolina Charleston, South Carolina, United States

View Trial Details

Completed

Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study

NCT00736255

Conditions: Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +8 more
Locations: Duke Attention Deficit Hyperactivity Disorder (ADHD) Program Durham, North Carolina, United States

View Trial Details

Completed

Open-Label Treatment Extension Study

NCT02896296

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
Locations: Boyett Health Services Hamilton, Alabama, United States

Woodland International Research Group Little Rock, Arkansas, United States

Collaborative Neuroscience Network Long Beach, California, United States

Pacific Research Partners Oakland, California, United States

View all 29 locations

View Trial Details

Completed

Reactions to E-cigs and Alcohol

NCT03449017

Conditions: Alcohol Abuse, Alcohol-Related Disorders, Alcoholism, +8 more
Locations: Indiana Univerisity Purdue University Indianapolis Indianapolis, Indiana, United States

View Trial Details

Substance-Related Disorders

Substance-Related Disorders trial results

Related conditions